XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
XORTX Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.01−0.23 (-18.55%)
Close on Oct 19, 2026
Dividends
XORTX Therapeutics has not reported a dividend
No dividend per share appears in XORTX Therapeutics's annual filings since fiscal 2018.